Mary Beth Seaman
About Mary Beth Seaman
Mary Beth Seaman serves as the Associate Director of Quality and Risk at Adaptimmune, bringing over 20 years of experience in the pharmaceutical and biopharmaceutical industries. She has a strong background in Quality Assurance and Compliance, with expertise in areas such as Quality Risk Management and Good Manufacturing Practice.
Current Role at Adaptimmune
Mary Beth Seaman serves as the Associate Director of Quality and Risk at Adaptimmune. She has held this position since 2022, contributing to the organization's focus on quality assurance and compliance in the biopharmaceutical sector. Her role involves overseeing quality risk management and ensuring adherence to regulatory standards.
Previous Experience at GSK
Mary Beth Seaman has extensive experience at GlaxoSmithKline (GSK), where she worked in various capacities from 1991 to 2017. She began as a Senior Quality Assurance Investigator, then advanced to the role of Product Quality Leader, and later served as GMP Compliance Manager. Her tenure at GSK spanned over 16 years, during which she gained significant expertise in quality assurance and compliance.
Education and Expertise
Mary Beth Seaman earned both her Bachelor of Science and Master of Science degrees in Chemistry from Saint Joseph's University. Her educational background supports her expertise in Quality Risk Management, Change Control, Investigations, and Root Cause Analysis. She is well-versed in preparing for Pre-Approval Inspections, reflecting her strong foundation in the pharmaceutical industry.
Industry Experience and Skills
Mary Beth Seaman has over 20 years of experience in the pharmaceutical and biopharmaceutical industries, with a specialization in Quality Assurance and Compliance. She possesses extensive knowledge of Good Manufacturing Practices (GMP) gained through her work in both clinical and commercial operations. Her strong program and project management skills complement her role as a motivated team leader.